BEHRENS M KATHLEEN bought SRPT
March 10, 2025 · Form 4 insider transaction
BEHRENS M KATHLEEN bought 2,383 shares of Sarepta Therapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,383
Price
N/A
Total value
N/A
InsiderBEHRENS M KATHLEEN
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 10, 2025
Filing dateMarch 11, 2025
Shares owned after193,476
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.